Bio Nebraska testifies in support of LB784
Rob Owen, Executive Director of Bio Nebraska, testified in support of funding for wet lab space and development of biosciences companies. Read more
Bio Industry
Member Spotlight: Baird Holm
For this month’s Member Spotlight, we talked to Baird Holm, an Omaha-based law firm representing nonprofit organizations, governmental entities, public and private companies, individuals, private funds and other investors, and financial institutions. Read more
Lincoln Journal Star recaps 2022 startup funding
Matt Olberding, Lincoln Journal Star, highlights last year’s venture capital funding in Lincoln, including mentions of Bio Nebraska members. Read more
Bio Nebraska testifies in support of LB491
Rob Owen, Executive Director of Bio Nebraska, testified in support of renewing the Nebraska Advantage Research and Development Act. Read more
UNL Report Shows Success of Business Innovation Act in Supporting Startups
The Nebraska Department of Economic Development announced that a new report by the University of Nebraska-Lincoln Bureau of Business Research shows a strong return on investment from the State’s Business Innovation Act programs. Read more
Bluestem Biosciences files to obtain patents
Bluestem Biosciences, a member of Bio Nebraska, announced it has filed 24 patent applications to protect its anaerobic chemical platform. Read more
Bill Anderson to become CEO of Bayer AG
Bayer, a member of Bio Nebraska, announced that the Supervisory Board of Bayer AG has appointed Bill Anderson to become CEO, effective June 1, 2023. Read more
Member Spotlight: Centese
For our February Member Spotlight, we talked to Centese, an early-stage medical device company that was founded to help patients recover from surgery faster and with fewer complications. Read more
Aeolian Biotech Formed to Create an Improved Pneumococcal Vaccine
Aeolian Biotech, a member of Bio Nebraska, announced the formation and launch of its company to focus on the development of an improved pneumococcal vaccine to address the threat of circulating and emerging pneumococcal serotypes. Read more
Member Spotlight: Aeolian Biotech
We are kicking off the new year with Aeolian Biotech as our January Member Spotlight. We spoke to Aeolian’s President and CEO, Tyler Martin, M.D., about the company’s pneumonia vaccine and what’s on the horizon for 2023. Read more